Radiotherapy & Oncology
Volume 103, Issue 2 , Pages 199-205, May 2012

Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery

  • Salvatore Terrazzino

      Affiliations

    • University of Piemonte Orientale “Amedeo Avogadro,” DiSCAFF and Centro di Ricerca Interdipartimentale di Farmacogenetica e Farmacogenomica (CRIFF), Novara, Italy
  • ,
  • Pierdaniele La Mattina

      Affiliations

    • University of Piemonte Orientale “Amedeo Avogadro” and Department of Radiotherapy, University Hospital Maggiore della Carità, Novara, Italy
  • ,
  • Laura Masini

      Affiliations

    • University of Piemonte Orientale “Amedeo Avogadro” and Department of Radiotherapy, University Hospital Maggiore della Carità, Novara, Italy
  • ,
  • Tina Caltavuturo

      Affiliations

    • University of Piemonte Orientale “Amedeo Avogadro” and Department of Radiotherapy, University Hospital Maggiore della Carità, Novara, Italy
  • ,
  • Giuseppina Gambaro

      Affiliations

    • University of Piemonte Orientale “Amedeo Avogadro” and Department of Radiotherapy, University Hospital Maggiore della Carità, Novara, Italy
  • ,
  • Pier Luigi Canonico

      Affiliations

    • University of Piemonte Orientale “Amedeo Avogadro,” DiSCAFF and Centro di Ricerca Interdipartimentale di Farmacogenetica e Farmacogenomica (CRIFF), Novara, Italy
  • ,
  • Armando A. Genazzani

      Affiliations

    • University of Piemonte Orientale “Amedeo Avogadro,” DiSCAFF and Centro di Ricerca Interdipartimentale di Farmacogenetica e Farmacogenomica (CRIFF), Novara, Italy
  • ,
  • Marco Krengli

      Affiliations

    • University of Piemonte Orientale “Amedeo Avogadro” and Department of Radiotherapy, University Hospital Maggiore della Carità, Novara, Italy
    • Corresponding Author InformationCorresponding author. Address: Department of Radiotherapy, University Hospital Maggiore della Carità, Novara, Italy.

Received 27 July 2011; received in revised form 5 October 2011; accepted 10 December 2011. published online 16 January 2012.

Abstract 

Purpose

To evaluate the impact of functional polymorphisms in genes related to DNA repair mechanisms (XRCC1, TP53, MSH2, MSH3, XPD), oxidative stress response (GSTP1, GSTA1, eNOS, SOD2) and fibroblast proliferation (TGFβ1) on the risk of acute skin toxicity in breast cancer patients receiving radiotherapy.

Material and methods

Skin toxicity was scored according to the Radiation Therapy Oncology Group criteria in 286 breast cancer patients who received radiotherapy after breast conserving surgery. Genotyping was conducted by PCR-RFLP analysis and real-time PCR allelic discrimination assay on genomic DNA extracted from peripheral blood.

Results

In the multivariate analysis, nominally significant associations, before multiple testing corrections, were found between XRCC1 T-77C (T carriers vs. CC, OR: 2.240, 95% CI: 1.015–4.941, P=0.046), eNOS G894T polymorphisms (TT vs. G carriers, OR: 2.473, 95% CI: 1.220–5.012, P=0.012), breast diameter (OR: 1.138, 95% CI: 1.001–1.293, P=0.048), boost dose-fractionation (3Gy vs. no boost, OR: 4.902, 95% CI: 1.458–16.483, P=0.010) and ⩾grade 2 acute radiation skin toxicity in breast cancer patients.

Conclusions

As our exploratory study suggests that XRCC1 T-77C and eNOS G874T may confer an increased risk of acute skin reactions to radiotherapy in breast cancer patients, further confirmatory studies are warranted to determine the clinical significance.

Keywords: Acute skin reaction, Breast cancer, Radiotherapy, Single nucleotide polymorphisms

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(11)00737-7

doi:10.1016/j.radonc.2011.12.002

Radiotherapy & Oncology
Volume 103, Issue 2 , Pages 199-205, May 2012